Reflecting on his company’s achievement, Dr. Mehran Talebinejad, founder of NeuroQore, noted: "Receiving the FDA clearance is a testament to the NeuroQore team's unwavering commitment and expertise. It is more than a milestone for us; it is the dawn of innovative treatment possibilities for those we serve."
Also rising to new levels this year was Mobio Interactives. Epígnosi, Mobio’s app created to address eating disorders in children, was green lit by Health Canada for human trials. This digital health tool, co-developed with the Children’s Hospital of Eastern Ontario, aims to reduce symptoms of depression and anxiety, negative body image, and food impulsivity through psychotherapy as well as automated feedback on mental wellbeing via Mobio’s mobile platform.
Big things are also happening for Dr. Alison Smith of Roga. Through an agreement with India’s GlobalSpace Technologies, a telehealth company, her wearable device created to help manage stress and burnout is now offered directly to patients.
And finally, Dr. Nardin Samuel of Cove Neurosciences, who is developing technology to discover and implement patient-specific biomarkers of brain disorders and other diseases, was featured in the FoundersBeta Top 100 Companies to Watch list as well as named as a trailblazing Canadian entrepreneurial at the Women Empowerment Awards.
Dr. Samuel, who received OBI NERVE funding in 2022 and ran a project with the Centre for Analytics earlier this year, said that her team is grateful for the Ontario Brain Institute's ongoing support.
